More than
1,200 users across all 15 Grünenthal affiliates in Europe and Australia are
replacing their various server-based CRM systems with a single, cloud-based
solution: Veeva CRM. The company selected Veeva to support its new centralised
business model, tearing down regional silos and uniting its selling effort
across the enterprise. According to Grünenthal, each region had operated its
own CRM system - none of which "talked to one another." So, the pharmaceutical
leader searched for aflexible system that would align with the company's new
vision.
After an in-depth evaluation and head to head
comparison of more than ten CRM providers, Grünenthal executives agreed that
Veeva CRM was the one system that could meet all of the company's needs. "We
were looking for a system that enabled seamless data sharingamongall our
commercial teamsacross the enterprise plus provide full geographic coverage of
Europe and Australia," said Martine Delage, Head of Field Force developmentfor
Grünenthal Europe & Australia. "So we ran a Veeva CRM pilot in the Nordics
and were very impressed with the unprecedented implementation speed and
reliability."
Grünenthal reports that the inherent flexibility and
openness of Veeva CRM's cloud-based platform were also appealing. "We were very
impressed with the possibility of being able to integrate other systems on a
common CRM platform in the future. And the cloud gives us the insurance of adequate
capacity for data storage that server-based systems cannot guarantee," added
Delage.
The company also expressed satisfaction with Veeva's
global support team that implemented the new CRM system. "Veeva
workscollaboratively while also speaking in one voice. Theircommitment to
quality, customer focus and innovative vision matched our own," said Chris-Carol
Bremer, Grünenthal's Head of Marketing.
Five years ago, Veeva introduced the first cloud-based
CRM system designed specifically for pharmaceutical and biotechnology
organisations. Today, Veeva CRM supports tens of thousands of users globally,
including 17 of the top 20 largest global pharmaceutical companies. Most
recently, Veeva launched iRep - the industry's leading,integrated CRM and CLM
application for the Apple iPad. Grünenthal is piloting iRep in its Nordics
region with the expectation that it will roll out the new application
company-wide in the future.
"We are building a centralised,customer-focused
organisation. Veeva's vision, support and powerful cloud-based CRM system will
allow us to do that," continued Grünenthal's Bremer.
"Grünenthal's customer-centric commercial vision
combined with their world-class business and IT organisations have set a new
high standard for both market leadership and execution excellence," said Dan
Goldsmith, general manager, Veeva Europe. "Veeva is delighted to be part of
Grünenthal's transformation and we look forward to a strong partnership focused
on innovation and customer success," concluded Goldsmith.
For more information about Veeva CRM visit
www.veevasystems.com.
About
Grünenthal
The
Grünenthal Group is an independent, family-owned international research based
pharmaceutical company headquartered in Aachen, Germany. Building on its unique
position in pain, its objective is to become the most patient-centric company
to be a leader in therapy innovation.
Grünenthal
is one of the last five research-oriented pharmaceutical corporations with
headquarters based in Germany which sustainably invests in research and
development. These investments amounted to about 25% of revenues in 2011.
Grünenthal's research and development strategy concentrates on select fields of
therapy and state-of-the-art technologies. Grünenthal focus on the intensive
search for new ways to treat pain better, more effectively and with fewer
side-effects than before.
Altogether,
the Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal
products are sold in more than 155 countries and approx. 4,200 employees are
working for the Grünenthal Group worldwide. In 2011, Grünenthal reached estimated
revenues of €947 million.
About Veeva
Systems
Veeva Systems is the leader in cloud-based business
solutions for the global life sciences industry. Committed to innovation,
product excellence and customer success, Veeva has over 150 customers, ranging
from the world's largest pharmaceutical companies to emerging biotechs. Founded
in 2007, Veeva is a privately held company headquartered in the San Francisco
Bay Area, with offices in Philadelphia, Barcelona, Paris, Beijing, Shanghai and
Tokyo.